JONES v. KIJAKAZI

District Court, M.D. North Carolina·Decided July 22, 2021·No. 1:20-cv-00516·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF NORTH CAROLINA

BENNY R. JONES, JR., ) ) Plaintiff, ) ) v. ) ) 1:20CV516 KILOLO KIJAKAZI, Acting ) Commissioner of Social Security1, ) ) Defendant. )

ORDER On May 24, 2021, in accordance with 28 U.S.C. § 636(b), the Recommendation of the United States Magistrate Judge was filed and served on the parties in this action, and a copy was given to the court. (ECF No. 16). Within the time limitation set forth in the statute, counsel for Plaintiff objected to the Recommendation. (ECF No. 18.) None of these objections have merit and only one (id. at 1-7) requires a brief discussion. More specifically, citing Dowling v. Comm’r of SSA, 986 F.3d 377 (4th Cir. 2021), Plaintiff faults the ALJ for not considering the factors set forth in 20 C.F.R. § 404.1527(c) in evaluating Dr. Schorn’s opinion. (ECF No. 18 at 2.) See 20 C.F.R. § 404.1527(c) (listing relevant factors as whether the relationship is an examining relationship and/or a treating relationship as well as: (1) the length of the treatment relationship, (2) the frequency of examination, (3) the nature

1 President Joseph R. Biden, Jr. appointed Kilolo Kijakazi as the Acting Commissioner of Social Security on July 9, 2021. Pursuant to Rule 25(d) of the Federal Rules of Civil Procedure, Kilolo Kijakazi should be substituted for Andrew M. Saul as the Defendant in this suit. Neither the court nor the parties need take any further action to continue this suit by reason of the last sentence of section 205(g) of the Social Security Act, 42 U.S.C. § 405(g). and extent of the treatment relationship, (4) supportability, (5) the consistency, (6) whether the source is a specialist, and (7) any other factor that may support or contradict the opinion). Nevertheless, Plaintiff admits that the ALJ considered the factors of supportability and

consistency. (Docket Entry 18 at 2-3, Tr. 20-21.) and, a review of the ALJ’s decision demonstrates that the ALJ considered the remaining factors as well. Specifically, the ALJ explicitly indicated that she considered the relevant factors when she stated, “The undersigned has also considered opinion evidence in accordance with the requirements of 20 CFR 404.1527 . . . .”2 (Tr. 19.) Consequently, Plaintiff’s contention that the ALJ failed to consider the regulatory factors is contradicted by the ALJ’s explicit statement

that she did, in fact, consider them. The ALJ also explicitly considered Plaintiff’s longitudinal relationship with Dr. Schorn, whom he described as one of Plaintiff’s “treating providers at Pinehurst Medical Clinic.” (Tr. 21.) Dr. Schorn examined Plaintiff a number of times over a number of years and the ALJ addressed most—if not all—of these examinations by exhibit.3 To do this, the ALJ necessarily

2 See, e.g., Carter v. Colvin, No. 1:13CV334, 2016 WL 1735885, at *12 (M.D.N.C. May 2, 2016) (concluding ALJ’s statement that he considered medical opinions in light of 20 C.F.R. § 404.1527 supported conclusion that the relevant regulatory factors had been considered).

3 (See Tr. 20, 323, 325 (9/12/2016, “…. patient has had well controlled rheumatoid arthritis on this regimen,” “well nourished, well developed, no acute distress,” “no active synovitis, joint deformities, mulp nodules”); Tr. 20, 21, 320, 322 (01/16/2017, “patient . . . is doing very well on his current regimen for control of his rheumatoid arthritis,” “no acute distress,” “no active synovitis, join deformities, mulp nodules,”); Tr. 364, 366 (5/17/2017, “patient has had well controlled rheumatoid arthritis” and normal muscle strength); Tr. 21, 417, 421 (10/16/2017, “ran out of Enbrel,” “[m]ild synovitis of hands and wrists off Enbrel,” “well nourished, well developed, no acute distress,” “muscle strength 5/5 throughout”); Tr. 20, 21, 479, 482-83 (03/19/2018 (enlargement of several joints in hands and nodules in hands and elbows but “muscle strength 5/5 throughout,” “well nourished, well developed, no acute distress”); Tr. 20, 21, 525, 529, 08/22/2018 (same); Tr. 20, 21, 546, 549 (10/23/2018, “no morning stiffness and good control of his rheumatoid arthritis,” “well nourished, well developed, no acute distress,” “[n]o active synovitis[,] multiple rheumatoid nodules[,] destruction of hands[,] wrist[,] elbows and feet[,] marked crepitation range of motion of both knees”); Tr. 20, 21, 553, 556 (01/23/2019, must have considered the examining relationship and the nature, length and frequency of that relationship. Dr. Schorn’s treatment notes, as well as her medical opinions—which the ALJ cited

and discussed—are also replete with references to her specialization in rheumatology. (Tr. 20- 21, 320, 322, 325, 333, 365, 543.) In fact, the record clearly demonstrates that the ALJ was aware that Dr. Schorn specialized in rheumatology, because at the administrative hearing, Plaintiff’s attorney explained that “Pinehurst Medical Clinic . . . is the rheumatologist,” (Tr. 33), to which the ALJ responded, “Which is the rheumatology, right.” (Tr. 33.) It is very difficult to believe that the ALJ could have written the decision she did without taking into

consideration Dr. Schorn’s specialization in rheumatology, and even assuming for the sake of argument that the ALJ failed to consider this factor (which does not appear to be the case) the error was harmless. Ultimately, the problems with Dr. Schorn’s vague, conclusory, and unsupported opinions—which were addressed by the ALJ and the Magistrate Judge (Tr. 20- 21, Docket Entry 16 at 9-14)—were irrelevant to her specialization. As for the “other factor” catch-all category, Plaintiff fails to assert precisely what “other

factor” the ALJ purportedly failed to consider (if any) in weighing Dr. Schorn’s opinions. In any event, the ALJ accurately noted that the non-examining state agency physician considered the existing record (and in doing so referenced some of Dr. Schorn’s treatment notes) and found Plaintiff to be limited to light—rather than sedentary—work. (Tr. 21, 83-86, 92-94.) Thus, the ALJ demonstrated that the opinion of the non-examining state agency physician

(“marked improvement in his synovitis and joint symptoms he still has significant destruction and significant nodules,” “normal balance, muscle strength 5/5 throughout”).) contradicted Dr. Schorn’s opinion as to Plaintiff’s limitations. The non-examining state agency physician, who the ALJ found partially persuasive, noted in his analysis that Plaintiff regularly exhibited, for example, a normal and steady gait and the medical record repeatedly

bears this out. (Tr. 83, 85, 91, 93, 358, 361, 380, 407, 442, 477, 504, 509, 512, 515, 540, 566.) In fact, the ALJ pointed to many of these records in support of her decision.4 (Tr. 17, 20-21, 358, 407, 442, 504, 509.) All things considered, the ALJ gave good reasons for rejecting Dr. Schorn’s opinions, including her conclusion that Plaintiff could not stand or walk.5 In light of all this, the instant case is distinct from Dowling. In Dowling—unlike this case—the ALJ ignored most of the relevant factors and “simply declared that he possessed

Free access — add to your briefcase to read the full text and ask questions with AI

JONES v. KIJAKAZI, (M.D.N.C. 2021).

JONES v. KIJAKAZI (JONES v. KIJAKAZI) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Lakenisha Dowling v. Commissioner of SSA
986 F.3d 377 (Fourth Circuit, 2021)